AbbVievsEli Lilly and Company

ABBV and LLY stock compared: price, dividend, valuation and results, from SEC filings.

LLY

Eli Lilly and Company

$1,431.67

Value $1.35T

-0.82%
LLY's page

AbbVie (ABBV) has a market value of $521B and Eli Lilly and Company (LLY) $1.35T. Over the last year, with dividends, ABBV moved +30.6% and LLY +40.5%. The P/E is 50.6 for ABBV and 49.0 for LLY. Dividend yield: ABBV 2.35%, LLY 0.44%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$521B

    LLY$1.35T

    LLY is 2.6 times ABBV

  • Revenue, 12 months

    ABBV$66.0B

    LLY$86.5B

    LLY is 1.3 times ABBV

  • Net income, 12 months

    ABBV$10.3B

    LLY$27.6B

    LLY is 2.7 times ABBV

  • Operating margin

    ABBV32.2%

    LLY–

  • ROIC

    ABBV25.7%

    LLY35.5%

    9.8 points apart

  • P/E

    ABBV50.6

    LLY49.0

    About the same

  • Dividend yield

    ABBV2.4%

    LLY0.4%

    2.0 points apart

  • 5-year return

    ABBV+201.4%

    LLY+478.4%

    277.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.4%

LLY+478.4%

20040060020222023202420252026
Returns by period
PeriodABBVWith dividendsLLYWith dividends
1 year since November 14, 2025+30.6%Price +26.8%+40.5%Price +39.6%
3 years since November 16, 2023+135.5%+33.0% a yearPrice +113.0%+148.1%+35.4% a yearPrice +143.2%
5 years since November 15, 2021+201.4%+24.7% a yearPrice +152.1%+478.4%+42.1% a yearPrice +454.0%
10 years since November 16, 2016+619.6%+21.8% a yearPrice +378.6%+2,064.5%+36.0% a yearPrice +1,760.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieLLYEli Lilly and Company

Valuation

ABBVLLY
Valuation
Price$294.55$1,431.67
Market value$521B$1.35T
Enterprise value (EV)$591B$1.40T
P/E50.649.0
P/E, 5-year median57.049.9
P/B–33.5
EV/EBIT27.840.1
Free cash flow yield3.6%1.5%

Results and growth

ABBVLLY
Results and growth
Revenue, 12 months$66.0B$86.5B
Net income, 12 months$10.3B$27.6B
Free cash flow, 12 months$18.9B$19.7B
Earnings per share, 12 months$5.81$30.81
Revenue growth, year on year8.6%44.7%
Revenue growth a year, past+5.9%over 5 years+21.6%over 5 years
EPS growth a year, past-2.8%over 5 years+27.6%over 5 years

Margins and returns on capital

ABBVLLY
Margins and returns on capital
Gross margin73.7%83.6%
Operating margin32.2%–
Net margin15.7%31.9%
ROIC25.7%35.5%
ROE–88.6%

Balance sheet

ABBVLLY
Balance sheet
Cash$10.8B$4.9B
Total debt$80.9B$49.5B
Net debt / EBITDA3.21.2
Interest cover7.1×38.9×

Dividends and buybacks

ABBVLLY
Dividends and buybacks
Dividend yield2.4%0.4%
Dividend per share, 12 months$6.92$6.34
Dividend growth a year, past+6.6%over 5 years+15.2%over 5 years
Buyback yield0.2%0.3%
Shareholder yield2.5%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.35T) is about 2.6 times AbbVie ($521B), at today's prices.

How did ABBV and LLY stock do over the last 10 years?

Since November 16, 2016, ABBV's price moved +378.6% and LLY's +1,760.8%. With dividends: ABBV +619.6% (+21.8% a year), LLY +2,064.5% (+36.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or LLY?

The dividend yield at today's price is 2.35% for AbbVie and 0.44% for Eli Lilly and Company. Over the last twelve months they paid $6.92 and $6.34 per share.

What is the P/E of ABBV and LLY?

At today's price, the P/E is 50.6 for ABBV and 49.0 for LLY. The median of the last five years was 57.0 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or Eli Lilly and Company?

Over the last twelve months, the net margin was 15.7% for AbbVie and 31.9% for Eli Lilly and Company, and the operating margin 32.2% and –. Revenue was $66.0B and $86.5B.

Which is the better investment, AbbVie or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.